GEORGINA KNOPPS: Open Payments
NPI 1386019636 · FYFFE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$185 in 8 payments from 7 companies in 2025. Trend: 2023 $158 · 2024 $59 · 2025 $185
Food & beverage: $185
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Corcept Therapeutics | 1 | $36 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Novo Nordisk Inc | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: CAPLYTA, JARDIANCE, Korlym, TRELEGY ELLIPTA, Ozempic, Kerendia.
Industry payments across AL — which companies pay providers there.
